THE PHARMACIST’S ROLE IN THE DISPENSING METHYLFENIDATE IN THE TREATAMENT OF ADHD IN CHILDREN
DOI:
https://doi.org/10.61164/rmnm.v12i1.3130Keywords:
Methylphenidate, ADHD, Pharmaceutical care, Side effects, Treatment adherence.Abstract
Methylphenidate is widely used in the treatment of children with Attention Deficit Hyperactivity Disorder (ADHD), offering significant improvements in attention, control of hyperactivity and reduction of impulsivity. However, its use is associated with several side effects and risks, including insomnia, loss of appetite and potential impacts on growth and cardiovascular health, highlighting the importance of pharmaceutical attention. Continuous guidance from the pharmacist is essential to optimize treatment adherence, identify and manage adverse effects, and ensure safe and effective medication administration. This study reviews the existing literature on the role of pharmaceutical care in the management of ADHD with methylphenidate, presenting evidence that pharmaceutical intervention can significantly improve therapeutic outcomes and quality of life for pediatric patients. The integrated approach, which combines the use of methylphenidate with behavioral and educational interventions, is also highlighted as an effective strategy for promoting coping and self-regulation skills in children.
Downloads
References
ANDRADA, Jaqueline Gomes; CARVALHO, Alcione Silva. O uso de ritalina em pacientes com TDAH. Revista Ibero-Americana De Humanidades, Ciências E Educação, v. 9, n. 4, p. 9544-9554, 2023.
ANGONESI, Daniela; SEVALHO, Gil. Atenção Farmacêutica: fundamentação conceitual e crítica para um modelo brasileiro. Ciência & Saúde Coletiva, v. 15, p. 3603-3614, 2020.
BATISTA, José Márcio Machado. Estudo farmacoterapêutico e farmacogenético em crianças e adolescentes com transtorno do déficit de atenção e hiperatividade tratados com metilfenidato. 2016.
BATISTA, Sabrina de Cássia Macêdo; SANTOS, Cláudia Valéria; ANDRADE, José Carlos; PEREIRA, Ana Luiza; GOMES, Ricardo Alex.
Polimedicação, atenção farmacêutica e cuidado farmacêutico. BIOFARM-Journal of Biology & Pharmacy and Agricultural Management, v. 16, n. 4, p. 455-469, 2020.
COSTA, Monize Evelin Araujo; OLIVEIRA, Joelma Coelho Pina. A importância da atenção farmacêutica no uso racional de medicamentos. SAÚDE & CIÊNCIA EM AÇÃO, v. 8, n. 1, p. 109-129, 2022.
FRANÇA, Maria Thereza de Barros. Transtorno de déficit de atenção e hiperatividade (TDAH): ampliando o entendimento. Jornal de Psicanálise, v. 45, n. 82, p. 191-207, 2015.
MELO, Thaísa Martins; CARVALHO, Alcione Silva; DE ANDRADE, Leonardo Guimarães. O uso do metilfenidato em pacientes com TDAH. Revista Ibero-Americana de Humanidades, Ciências e Educação, v. 8, n. 4, p. 891-900, 2022.
MENG, Laura Christina Hagers; RIBEIRO, Roberto Carlos. TRANSTORNO DE DÉFICIT DE ATENÇÃO COM HIPERATIVIDADE (TDAH). SEPE-Seminário de Ensino, Pesquisa e Extensão da UFFS, v. 12, 2023.
OLIVEIRA, Andrezza Beatriz; COSTA, Daniela Ramos; ALMEIDA, Júlia Maria; PEREIRA, Luciana. Obstáculos da atenção farmacêutica no Brasil. Revista Brasileira de Ciências Farmacêuticas, v. 41, p. 409-413, 2015.
PASTURA, Giuseppe; MATTOS, Paulo. Efeitos colaterais do metilfenidato. Archives of Clinical Psychiatry (São Paulo), v. 31, p. 100-104, 2024.
PEREIRA, Leonardo Régis Leira; FREITAS, Osvaldo de. A evolução da Atenção Farmacêutica e a perspectiva para o Brasil. Revista Brasileira de Ciências Farmacêuticas, v. 44, p. 601-612, 2018.
SILVA, Daniela Santana. O uso do metilfenidato (Ritalina) em pacientes com Transtorno de Déficit de Atenção e Hiperatividade: mecanismo de ação e os efeitos adversos do medicamento. Revista de Trabalhos Acadêmicos da FAM, v. 3, n. 1, 2018.
VIEIRA, Emelin Grazielle de Souza; MASTROROCCO FILHO, Diogo Antonio Morato. Descrição e utilização do Metilfenidato. Revista Científica Eletrônica de Ciências Aplicadas da FAIT, n. 1, 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
